95260 ⎘
Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Salt form of a human histone methyltransferase EZH2 inhibitor
#2102Somatostatin receptor subtype 4 (SSTR4) agonists
#2103Substituted sulfonyl amides for controlling animal pests
#2104Substituted piperidine compound and use thereof
#2105Chromene derivatives as inhibitors of TCR-NCK interaction
#2106Substituted chromenes for treatment of fibrosis or non-alcoholic steatohepatitis
#2107Glucosylceramide synthase inhibitors for the treatment of diseases
#2108Processes for preparing antiviral compounds
#2109ACSS2 inhibitors and methods of use thereof
#21103-phenyl-pyrazole derivatives as modulators of the 5-HTserotonin receptor useful for the treatment of disorders related thereto
#2111Antiviral compounds
#2112Hydroxyl compounds and compositions for cholesterol management and related uses
#2113Pyridine and Pyrazine Derivative for the Treatment of CF
#2114Phthalazinone compounds and methods for the treatment of cystic fibrosis
#2115Alpha-synuclein ligands
#2116Diaryl thioether piperazine compounds, preparation methods and uses thereof
#2117Compositions and methods for inhibition of the JAK pathway
#2118Kinase inhibitors for the treatment of disease
#2119DNA-PK inhibitors
#21202,4-pyrimidinediamine compounds and their uses
#2121DNA primase and gyrase inhibitors
#2122ULK1 inhibitors and methods using same
#2123Bicyclic derivatives, a process for their preparation and pharmaceutical compositions containing them
#2124Method for purifying benzopyran derivative, crystal form thereof, and method for preparing crystal form
#2125Pyridone amides as modulators of sodium channels
#2126SALTS AND PRODRUGS OF 1-METHYL-D-TRYPTOPHAN
#2127Phenyl phthalazine derivative, method for the preparation thereof, and pharmaceutical composition comprising the same
#2128SUBSTITUTED INDAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS
#21293-substituted carbonyl-naphtho[2,3-B]furane derivative or pharmaceutically acceptable salt thereof
#2130Compounds and compositions for inhibition of FASN
#2131Compounds and compositions for inhibition of FASN
#2132Benzyl phenyl ether derivative, preparation method therefor, and pharmaceutical composition and uses thereof
#2133SODIUM CHANNEL BLOCKERS
#2134Hsp70 modulators and methods for making and using the same
#2135Benzylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
#2136Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
#2137Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
#2138Small molecules against cancer
#2139Phenylate derivative, preparation method therefor, and pharmaceutical composition and uses thereof
#2140PRODRUGS OF TETRAHYDROCANNABINOL, COMPOSITIONS COMPRISING PRODRUGS OF TETRAHYDROCANNABINOL AND METHODS OF USING THE SAME
#2141Guanidine derivative and medical use thereof
#21423-amino-1,2,4-triazine derivatives and their use for controlling undesired plant growth
#2143Chemokine CXCR1 and CXCR2 receptor antagonist compounds, and use thereof in the treatment of chemokine-mediated pathologies
#2144Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same
#2145ANTI-INFECTIVE AGENTS
#2146INDAZOLYL- AND INDOLYL-BENZAMIDE DERIVATIVES
#2147HETEROARYL COMPOUNDS FOR KINASE INHIBITION
#2148Furane derivatives as inhibitors of ATAD2
#2149ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF
#2150Small molecule regulators of steroid receptor coactivators and methods of use thereof
#2151Activators of class I histone deacetylases (HDACs) and uses thereof
#2152Trans-indoline cyclopropylamine chemical compound, and method for preparation, pharmaceutical composition, and use thereof
#2153PROCESS OF PRODUCING CYCLOALKYLCARBOXAMIDO-INDOLE COMPOUNDS
#2154PHENYL QUINOLINONE DERIVATIVES AS MUTANT-ISOCITRATE DEHYDROGENASE INHIBITORS
#2155Azadecalin derivatives as inhibitors of human immunodeficiency virus replication
#2156COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
#2157Indazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma (T))
#2158PROCESSES FOR PREPARATION OF EMPAGLIFLOZIN
#2159Aminoacylindazole immunomodulators for treatment of autoimmune diseases
#2160Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
#2161Compositions and methods of using the same for treatment of neurodegenerative and mitochondrial disease
#2162Substituted ureas and methods of making and using same
#2163Quinazolinones as PARP14 inhibitors
#21646-hydroxy-5-(phenyl/heteroarylsulfonyl)pyrimidin-4(1H)-one as APJ agonists
#2165Dual NAV1.2/5HT2a inhibitors for treating CNS disorders
#2166Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
#2167Compounds for treating disorders sensitive to serotoninergic regulation controlled by the 5-HT1A receptors
#2168ARYL-OR HETEROARYL-SUBSTITUTED BENZENE COMPOUNDS
#2169HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS
#21702,4-disubstituted pyrimidines useful as kinase inhibitors
#2171Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
#2172Oxopicolinamide derivative, preparation method therefor and pharmaceutical use thereof
#2173AMINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME
#2174Inhibitors of fibroblast activation protein
#21751,3-dihydroxy-phenyl derivatives useful as immunomodulators
#2176Cannabinergic compounds and uses thereof
#2177Triazoles for the treatment of demyelinating dieases
#2178Compound for organic electronic device, organic electronic device using same, and electronic apparatus thereof
#2179Condensed-ring pyrimidylamino derivative, preparation method therefor, and intermediate, pharmaceutical composition and applications thereof
#2180Inhibitors of integrated stress response pathway
#2181TETRAZOLYL-CONTAINING CYCLOPROPANECARBOXAMIDES
#21822-pyrrolidine phenylhydrazides antibacterial agents
#2183Biaryl amide compounds as kinase inhibitors
#2184EZH2 INHIBITORS FOR TREATING LYMPHOMA
#2185Compounds and methods for kinase modulation, and indications therefor
#2186Crystalline form of N-[5-(3,5-difluoro-benzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide
#2187Heterocyclic compound
#2188Small molecule regulators of mitochondrial fusion and methods of use thereof
#2189Tubulin inhibitors
#2190Lipids and compositions for the delivery of therapeutics
#2191Methods for treating depressive symptoms
#2192METHODS FOR TREATING PULMONARY EMPHYSEMA USING SUBSTITUTED 2-AZA-BICYCLO[2.2.1]HEPTANE-3-CARBOXYLIC ACID (BENZYL-CYANO-METHYL)-AMIDES INHIBITORS OF CATHEPSIN C
#2193Compounds
#2194Plants having increased tolerance to herbicides
#2195Oxoacridinyl acetic acid derivatives and methods of use
#2196Indole derivatives and their use in neurodegenerative diseases
#2197Urea derivative or pharmacologically acceptable salt thereof
#2198Catecholamine prodrugs for use in the treatment of Parkinson's disease
#2199Compound for organic electronic element, organic electronic element using same, and electronic device comprising same
#2200PRO-DRUGS OF NSAIAS WITH VERY HIGH SKIN AND MEMBRANES PENETRATION RATES AND THEIR NEW MEDICINAL USES
#2201ULK1 inhibitors and methods using same
#2202Tetrahydroindazoles and medical uses thereof
#2203Compounds for treating parasitic infections
#2204Benzo-fused heterocyclic derivatives useful as agonists of GPR120
#2205NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS
#2206Compound and organic electronic element comprising same
#22071,4-substituted piperidine derivatives
#2208Complex and structurally diverse compounds
#2209ORGANIC LIGHT-EMITTING DEVICE
#2210Amino compounds for treatment of complement mediated disorders
#2211BIGUANIDE COMPOUNDS AND USE THEREOF
#2212Modulators of ATP-binding cassette transporters
#2213Fused tricyclic urea compounds as Raf kinase and/or Raf kinase dimer inhibitors
#2214Halogenated quinazolin-THF-amines as PDE1 inhibitors
#2215Quinazolines as potassium ion channel inhibitors
#22169-MEMBERED FUSED RING DERIVATIVE
#2217Inhibitors of integrin alpha 5 beta 1 and methods of use
#2218Chemical compounds
#2219MEK Inhibitors and Methods of Their Use
#2220Benzopyrazole compounds and analogues thereof
#2221Substituted Tricyclics and Method of Use
#2222CARM1 inhibitors and uses thereof
#2223Substituted pyrimidine-4-carboxylic acids having anticancer activity
#2224Indoline derivatives and method for using and producing the same
#2225Immunomodulator compounds
#2226Compound for organic electric element, organic electric element using same, and electronic device comprising same organic electronic element
#2227Methods of treating cancers overexpressing CARM1 with EZH2 inhibitors and platinum-based antineoplastic drugs
#2228MODULATORS OF CELLULAR ADHESION
#22291-arylalkyl-4-acylaminopiperidine compounds
#2230Fungicidal pyridazinones
#2231Compound for organic electronic element, organic electronic element using same, and electronic device thereof
#2232INHIBITORS OF HEPATITIS C VIRUS REPLICATION
#2233Compounds & Methods for the Enhanced Degradation of Targeted Proteins & Other Polypeptides by an E3 Ubiquitin Ligase
#2234Pyridazinone-based broad spectrum anti-influenza inhibitors
#2235Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
#2236Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases
#2237FUNGAL CONTROL OF WHITE MOLD
#2238COMPOSITIONS AND METHODS FOR TREATING CANCER
#2239Substituted carboxamides as inhibitors of WDR5 protein-protein binding
#2240N-acylurea derivative and composition comprising same for prevention or treatment of cardiovascular disease
#2241Methods and compounds for restoring mutant p53 function
#2242Pyridyl derivatives as bromodomain inhibitors
#2243Compounds and compositions for treating conditions associated with NLRP activity
#2244Modulators of indoleamine 2,3-dioxygenase
#2245PKM2 modulators and methods for their use
#2246Tyrosine kinase inhibitor and pharmaceutical composition comprising same
#2247Versatile ligand for palladium-catalyzed meta-C—H functionalizations of aromatic substrates
#2248Fluorinated lysyl oxidase-like 2 inhibitors and uses thereof
#2249Compounds and compositions for treating conditions associated with NLRP activity
#2250Compositions and methods for treating disorders of circadian and diurnal rhythms using prokineticin 2 agonists and antagonists
#2251Therapeutically active compounds and their methods of use
#2252Piperazine-Substituted Benzothiophenes For Treatment of Mental Disorders
#2253ACTIVATORS OF AUTOPHAGIC FLUX AND PHOSPHOLIPASE D AND CLEARANCE OF PROTEIN AGGREGATES INCLUDING TAU AND TREATMENT OF PROTEINOPATHIES
#2254Crystalline form of lumacaftor
#2255Heterocyclic inhibitors of MCT4
#2256MCT4 INHIBITORS FOR TREATING DISEASE
#22573-(CARBOXYMETHYL)-8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECANE DERIVATIVES
#2258Fused 1,4-dihydrodioxin derivatives as inhibitors of heat shock transcription factor I
#2259Ion pair catalysis of tungstate and molybdate
#2260Probe for selectively characterizing enzymes involved in xenobiotic metabolism and method of making and using the same
#2261Androgen receptor modulating compounds
#2262EGFR inhibitor, preparation method and use thereof
#2263METHODS OF TREATING CANCER
#2264Fluorinated cyclopropylamine compound, preparation method therefor, pharmaceutical composition thereof, and uses thereof
#22653-(CARBOXYETHYL)-8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECANE DERIVATIVES
#2266Arginine methyltransferase inhibitors and uses thereof
#2267HETEROCYCLIC SULFONAMIDES, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF
#2268Imaging composition and uses thereof
#2269N-CYCLOALKYL-N-[(HETEROCYCLYLPHENYL)METHYLENE]-(THIO)CARBOXAMIDE DERIVATIVES
#2270Photoelectric conversion element, two-dimensional sensor, image sensor, and image pickup device
#2271Benzimidazolone and benzothiazolone compounds and their use as AMPA receptor modulators
#2272Phosphonate compounds for treatment of complement mediated disorders
#2273Amide-sulfamide derivatives, compositions, and uses related to CXCR4 inhibition
#2274Pyrimidinyloxy benzene derivatives as herbicides
#2275FUMAGILLOL HETEROCYCLIC COMPOUNDS AND METHODS OF MAKING AND USING SAME
#2276FUMAGILLOL HETEROCYCLIC COMPOUNDS AND METHODS OF MAKING AND USING SAME
#2277Substituted naphtho[2,3-b]furans as water-soluble prodrugs for preventing and/or treating cancer
#2278Indole derivatives for use in medicine
#2279CYCLOALKYL-HYDROXYL COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES
#2280Aromatic ring compound
#22812-amino-5-ketoxime-pyrimidine derivatives and their use for controlling undesired plant growth
#2282ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF
#2283Compositions and methods for treating infections
#2284Bisamide sarcomere activating compounds and uses therof
#2285Voltage-dependent t-type calcium channel blocker
#2286Compositions for APP-selective BACE inhibition and uses therefor
#2287Benzazepine dicarboxamide compounds with secondary amide function
#2288Histone demethylase inhibitors
#2289Trigonelline based compounds
#2290Cholecystokinin B receptor targeting for imaging and therapy
#2291Modulators of ATP-binding cassette transporters
#2292Biguanide compositions and methods of treating metabolic disorders
#2293Derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine
#2294Benzimidazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma (T))
#22953-phosphoglycerate dehydrogenase inhibitors and uses thereof
#2296Wnt signaling pathway inhibitors for treatments of disease
#2297THERAPEUTIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF
#22983-phosphoglycerate dehydrogenase inhibitors and uses thereof
#2299Indole derivatives and their use as protein kinase inhibitors
#2300Combinations for the treatment of neuroblastoma
#2301PRIMARY AMINES AND DERIVATIVES THEREOF AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
#2302Substituted asymmetric ureas as modulators of ghrelin receptor activity
#2303Compounds
#2304Cyclopropylamines as LSD1 inhibitors
#23052,3-epoxy succinyl derivative, preparation method and use thereof
#2306Substituted heterocycles as c-MYC targeting agents
#2307Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
#2308C5aR ANTAGONISTS
#2309TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS
#2310SUBSTITUTED BENZENE COMPOUNDS
#2311Imidazolylamide derivative
#2312Use of picolinamide compounds as fungicides
#2313Glycosidase inhibitors
#2314Acid addition salts of piperazine derivatives
#2315Forms of lumacaftor and processes for the preparation thereof
#2316AHR inhibitors and uses thereof
#2317Methods for 1,4-diazo n-heterocycle synthesis
#2318Potent dual BRD4-kinase inhibitors as cancer therapeutics
#2319NUCLEAR RECEPTOR MODULATORS
#2320Ether compounds for treatment of complement mediated disorders
#2321Substituted pyrazin-2-amines as inhibitors of ATR kinase
#23226-ACYL-1,2,4-TRIAZINE-3,5-DIONE DERIVATIVE AND HERBICIDES
#2323NOVEL COMPOUND AND PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF
#2324Substituted benzenesulfonamides as inhibitors of alpha-4 beta-7 integrin activity
#2325Beta-arrestin-biased cannabinoid CBreceptor agonists and methods for making and using them
#2326MCL-1 antagonists
#2327Piperidine derivative
#2328Type of aryl benzofuran amidated derivative and medical use thereof
#2329Irreversible bruton's tyrosine kinase inhibitor
#2330ROR GAMMA (RORY) MODULATORS
#2331Heterocyclic compound and use thereof
#2332BICYCLIC COMPOUND, PRODUCTION AND USE THEREOF
#2333Compounds for treatment of complement mediated disorders
#2334Triazolo[4,5-D] pyramidine derivatives and their use as purine receptor antagonists
#2335Flavanone derivatives, and preparation method and use thereof
#2336PRODRUGS OF TETRAHYDROCANNABINOL, COMPOSITIONS COMPRISING PRODRUGS OF TETRAHYDROCANNABINOL AND METHODS OF USING THE SAME
#2337Tetrahydronaphthalene derivative
#2338Phenyl derivative
#2339Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
#2340Coumarin based HSP90 inhibitors with urea and ether substituents
#2341PRMT1 Inhibitors and Uses Thereof
#2342Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity
#2343DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS
#2344Carboxamides as modulators of sodium channels
#2345Compound for organic-electric element, organic-electric element using same, and electronic device for same
#2346REDUNDANT POWER LINE CONTROL SYSTEMS
#2347Prodrugs of urolithins and uses thereof
#2348α,β-unsaturated amide compound
#2349Sulfonamide compounds and uses as TNAP inhibitors
#23502-cyanoisoindoline derivatives for treating cancer
#2351BROMODOMAIN INHIBITORS
#2352Immunoregulatory agents
#2353NRF2 Regulators
#2354Inhibitors of β-hydroxylase for treatment of cancer
#2355Process for preparing lifitegrast and intermediates thereof
#2356CRYSTALLINE FORMS OF VILAZODONE HYDROCHLORIDE AND VILAZODONE FREE BASE
#2357Substituted amide derivatives having multimodal activity against pain
#2358Pyrimidines as sodium channel blockers
#2359Carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
#2360MTH1 inhibitors for treatment of inflammatory and autoimmune conditions
#2361Compounds
#2362Methods for treating Huntington's disease
#2363Controlling zones of electronic devices associated with power lines
#2364Methods and systems for wireless to power line communication
#2365METHODS OF TREATMENT USING PYRIDINONYL PDK1 INHIBITORS
#2366Heteroaryl substituted pyridyl compounds useful as kinase modulators
#2367Tank-binding kinase inhibitor compounds
#2368P-TOLUENESULFONATE FOR MEK KINASE INHIBITOR, METHOD OF PREPARATION THEREOF, AND METHOD OF USE THEREOF
#2369Compounds and compositions for inhibition of FASN
#2370SIP modulating agents
#2371PYRIDINE COMPOUNDS AS FUNGICIDES
#2372Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
#2373N-HYDROXYFORMAMIDE COMPOUNDS AND COMPOSITIONS COMPRISING THEM FOR USE AS BMP l, TLL1 AND/OR TLL2 INHIBITORS
#2374Spiropyrazine derivatives as inhibitors of non-apoptotic regulated cell-death
#2375Quinolone-3-diarylethers
#2376Pyrrolidine derivatives
#2377Fumigillol compounds and methods of making and using same
#2378Benzamide compounds and their use as herbicides
#2379Compound for organic electric device, organic electric device using same, and electronic device
#2380Human plasma kallikrein inhibitors
#2381(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
#2382Heterocyclic compound and organic light emitting diode containing same
#2383PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF
#2384SUBSTITUTED PYRIDINE AND PYRAZINE COMPOUNDS AS PDE4 INHIBITORS
#2385Modified compound of andrographolide
#2386Pyridine compounds as fungicides
#2387Carbon monoxide releasing norbornenone compounds
#2388N-SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF
#2389Rho kinase inhibitors
#2390Lactone-based probes and methods of use thereof
#2391Pyruvate kinase activators for use in therapy
#2392PYRAZOLYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF
#23936-HETEROARYLOXY- OR 6-ARYLOXY-QUINOLINE-2-CARBOXAMIDES AND METHOD OF USE
#2394Pyridine derivative
#2395Substituted pyrazolo[3,4-d]pyrimidines as kinase inhibitors
#2396Lactam compound derivative and application thereof
#2397Benzofuran derivative, preparation method thereof and use thereof in medicine
#2398Aziridinated triglycerides and polymers formed therefrom
#2399Aryl cyclopropyl-amino-isoquinolinyl amide compounds
#2400Derivatives of 5-(hetero)arylpyrazol-3-carboxylic amide or 1-(hetero)aryltriazol-4-carboxylic amide useful for the treatment of inter alia cystic fibrosis